Investigational Site Number 840009

Los Angeles, California 90073

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Neoplasm Malignant

Studies at this site

• Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed